Lodi Valley News.com

Complete News World

Neuralink steps up and the brain chip begins to develop real skills

Neuralink steps up and the brain chip begins to develop real skills

Neuralink, a company founded by Elon Musk, has made exceptional progress in… Neurotechnology.

In the first successfully implanted patient, the brain chip began to show its true capabilities, allowing the individual to carry out simple commands through telepathy.

Elon Musk recently announced that a human patient is now able to control a computer mouse cursor with just his thoughts, developing an important skill for research.

The remarkable progress represents a major milestone in the development of Neuralink's technology, with the company already planning its next steps.

Neuralink announces the first brain chip – Image: Cloning

The next goal is to expand the patient's capabilities further, aiming to get as many clicks of the mouse button as possible with just a thought, paving the way for even more impressive possibilities in the future.

The first steps to transplanting brain slices

At the end of January, Neuralink performed the first brain transplant in a human, called “telepathy.”

This item was listed by A Robot In a specific area of ​​the brain, which is responsible for controlling movement intention.

The device is intended to help people with quadriplegia, by allowing them to control electronics, such as computers and cell phones, with just their thoughts.

This has been one of Musk's largest investments, who is also the CEO of Tesla, X (formerly Twitter), and other companies.

Neuralink also intends to evaluate the safety of both the implant and the robot used in the surgery, in addition to monitoring the progress of the patient's abilities.

The goal is to examine three main aspects: the implant itself, the R1 robot, and the N1 user application, which is software that connects to the Neuralink implant and translates brain signals into computational routines.

For confidentiality reasons, Neuralink She chose not to provide additional information about the progress of the trial, including the status of the patient who received the first brain transplant.